Hospital push could shield seniors from preventable diseases
NCT ID NCT03587610
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This trial evaluates whether a hospital-based remedial vaccination strategy can improve Tdap-IPV (tetanus, diphtheria, pertussis, polio) vaccination rates in adults aged 65 and older in the Sarthe region of France. Participants are randomly assigned to receive either the remedial strategy or standard care, and the study measures changes in immunization coverage. The goal is to find an effective way to protect older adults from these serious infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tdap-IPV vaccine (tetanus, diphtheria, pertussis, polio)
What this could lead to
If successful, this approach could help increase vaccination coverage among older adults, reducing the risk of preventable diseases in this age group.
What could go wrong
The study is small and focused on one region in France, so results may not apply elsewhere. It tests a process, not a new vaccine, so the impact depends on how well hospitals adopt the strategy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VACCINATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Le Mans
Le Mans, 72 000, France